In a recent 13F filing, Steve Cohen's Point72 revealed it had completely exited its position in medical supply company Medline Inc. (MDLN) during the second quarter of 2026. The firm sold its entire stake of 3.30 million shares, which was previously valued at approximately $147.04 million.
This trade was disclosed in a quarterly report filed on August 14, 2026, but reflects trading activity that occurred between April 1 and June 30, 2026. During that quarter, Medline saw its stock decline; on August 5, the company lowered its full-year profit guidance, which led to a nearly 15% drop in its share price.